Int J Biol Sci 2021; 17(14):3702-3716. doi:10.7150/ijbs.63512 This issue

Research Paper

Suppression of neuronal cholesterol biosynthesis impairs brain functions through insulin-like growth factor I-Akt signaling

Ting Liu1,2#, Yang Li1,#, Baoyu Yang1, Haozhen Wang1, Chen Lu1, Alan K Chang1, Xiuting Huang1, Xiujin Zhang1, Ziyin Lu1, Xiuli Lu1✉, Bing Gao3✉

1. The School of Life Science, Liaoning University, Chongshanzhong-lu No.66, Huanggu-qu, Shenyang 110036, China
2. China Medical University-The Queen's University Belfast Joint College, China Medical University, Shenyang, 110122, China
3. School of Basic Medical Sciences, Shenyang Medical College, Shenyang, 110034, China
# Co-First author

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Citation:
Liu T, Li Y, Yang B, Wang H, Lu C, Chang AK, Huang X, Zhang X, Lu Z, Lu X, Gao B. Suppression of neuronal cholesterol biosynthesis impairs brain functions through insulin-like growth factor I-Akt signaling. Int J Biol Sci 2021; 17(14):3702-3716. doi:10.7150/ijbs.63512. Available from https://www.ijbs.com/v17p3702.htm

File import instruction

Abstract

Graphic abstract

Some relationship between abnormal cholesterol content and impairment of insulin/insulin-like growth factor I (IGF-1) signaling has been reported in the pathogenesis of Alzheimer's disease (AD). However, the underlying mechanism of this correlation remains unclear. It is known that 3-β hydroxycholesterol Δ 24 reductase (DHCR24) catalyzes the last step of cholesterol biosynthesis. To explore the function of cholesterol in the pathogenesis of AD, we depleted cellular cholesterol by targeting DHCR24 with siRNA (siDHCR24) or U18666A, an inhibitor of DHCR24, and studied the effect of the loss of cholesterol on the IGF-1-Akt signaling pathway in vitro and in vivo. Treatment with U18666A reduced the cellular cholesterol level and blocked the anti-apoptotic function of IGF-1 by impairing the formation of caveolae and the localization of IGF-1 receptor in caveolae of the PC12 cells. Downregulation of the DHCR24 expression induced by siRNA against DHCR24 also yielded similar results. Furthermore, the phosphorylation levels of IGF-1 receptor, insulin receptor substrate (IRS), Akt, and Bad in response to IGF-1 were all found to decrease in the U18666A-treated cells. Rats treated with U18666A via intracerebral injection also exhibited a significant decrease in the cholesterol level and impaired activities of IGF-1-related signaling proteins in the hippocampus region. A significant accumulation of amyloid β and a decrease in the expression of neuron-specific enolase (NSE) was also observed in rats with U18666A. Finally, the Morris water maze experiment revealed that U18666A-treated rats showed a significant cognitive impairment. Our findings provide new evidence strongly supporting that a reduction in cholesterol level can result in neural apoptosis via the impairment of the IGF-1-Akt survival signaling in the brain.

Keywords: Cholesterol suppression, DHCR24, IGF-1 signaling, Central neuronal system